Skip to content

QuidelOrtho Corporation QDEL AOCI - Cash Flow Hedge Reclassification (Next 12 Months)

AOCI - Cash Flow Hedge Reclassification (Next 12 Months) at other companies

Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$921.94M-51.4%
Enterprise value$3.88B-20.1%
P/S0.4×-0.3×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's aoci - cash flow hedge reclassification (next 12 months).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's AOCI - cash flow hedge reclassification (next 12 months)?
QuidelOrtho Corporation (QDEL) reported AOCI - cash flow hedge reclassification (next 12 months) of -$700K in Q1 2026.
How has QuidelOrtho Corporation's AOCI - cash flow hedge reclassification (next 12 months) changed year-over-year?
QuidelOrtho Corporation's AOCI - cash flow hedge reclassification (next 12 months) decreased by 115.9% year-over-year, from $4.4M to -$700K.